Here are five highlights:
1. ReBOSSIS is the sole biosynthetic bone scaffold with electrospun microfiber construction.
2. The product is designed for posterolateral spine procedures.
3. ReBOSSIS has yielded a 54 percent compression recovery rate.
4. Providers have used ReBOSSIS in more than 1,500 procedures.
5. ORTHOReBIRTH USA is a wholly owned subsidiary of ORTHOReBIRTH Co.
More articles on biologics:
Kleiner Device Labs unveils new spinal bone graft tool: 5 things to know
GI surgical sealant receives CE marking for sale in the EU — 5 insights
1st surgery to treat damaged cartilage with allogeneic stem cells in Japan — 6 key insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
